WAS and thrombocytopenia 1: More than 300 mutations have been described for WAS. Among them, mutations that lead to a complete loss of WASp synthesis are associated with the severe phenotype of WAS; on the other hand, mutations that only partially reduce WASp levels are associated with the milder XLT phenotype (18).